GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 107 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $285,000 | -8.7% | 11,909 | -40.8% | 0.00% | – |
| Q4 2020 | $312,000 | +88.0% | 20,105 | +72.0% | 0.00% | – |
| Q3 2020 | $166,000 | -27.8% | 11,690 | -5.0% | 0.00% | – |
| Q2 2020 | $230,000 | +2455.6% | 12,302 | +485.8% | 0.00% | – |
| Q1 2020 | $9,000 | -81.6% | 2,100 | -79.5% | 0.00% | – |
| Q4 2019 | $49,000 | +2.1% | 10,239 | +29.5% | 0.00% | – |
| Q3 2019 | $48,000 | -4.0% | 7,906 | +2.8% | 0.00% | – |
| Q2 2019 | $50,000 | +127.3% | 7,687 | +145.4% | 0.00% | – |
| Q1 2019 | $22,000 | +22.2% | 3,133 | -18.7% | 0.00% | – |
| Q4 2018 | $18,000 | -30.8% | 3,853 | +10.4% | 0.00% | – |
| Q3 2018 | $26,000 | +18.2% | 3,490 | -0.3% | 0.00% | – |
| Q2 2018 | $22,000 | +29.4% | 3,501 | +11.7% | 0.00% | – |
| Q1 2018 | $17,000 | +112.5% | 3,133 | +302.2% | 0.00% | – |
| Q3 2017 | $8,000 | -11.1% | 779 | 0.0% | 0.00% | – |
| Q2 2017 | $9,000 | -10.0% | 779 | 0.0% | 0.00% | – |
| Q1 2017 | $10,000 | +11.1% | 779 | 0.0% | 0.00% | – |
| Q4 2016 | $9,000 | 0.0% | 779 | 0.0% | 0.00% | – |
| Q3 2016 | $9,000 | -75.0% | 779 | -80.5% | 0.00% | – |
| Q2 2015 | $36,000 | -30.8% | 4,000 | 0.0% | 0.00% | – |
| Q1 2015 | $52,000 | +92.6% | 4,000 | +100.0% | 0.00% | – |
| Q4 2014 | $27,000 | +50.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2014 | $18,000 | -53.8% | 2,000 | -30.8% | 0.00% | – |
| Q2 2014 | $39,000 | +95.0% | 2,890 | +44.5% | 0.00% | – |
| Q1 2014 | $20,000 | -25.9% | 2,000 | 0.0% | 0.00% | – |
| Q4 2013 | $27,000 | +12.5% | 2,000 | 0.0% | 0.00% | – |
| Q3 2013 | $24,000 | +14.3% | 2,000 | 0.0% | 0.00% | – |
| Q2 2013 | $21,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|